Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about STREM2: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet.
No AI portrait yet
| Name | STREM2 |
| Key Genes/Proteins | TREM2 |
| Related Diseases | Neural Injury, Neuromyelitis Optica Spectrum Disorders, NMOSD |
| Related Pathways | Nfkb |
Knowledge base pages for this entity
graph TD
STREM2["STREM2"]
STREM2 -.biomarker for.-> Microglial_Activation["Microglial Activation"]
STREM2 -->|"risk_factor_for"| Neuromyelitis_Optica_Spectrum_["Neuromyelitis Optica Spectrum Disorders"]
STREM2 -->|"involved_in"| Proteolytic_Shedding["Proteolytic Shedding"]
STREM2 -.biomarker for.-> Alzheimer_s_disease["Alzheimer's disease"]
STREM2 -->|"correlates_with"| Neural_Injury["Neural Injury"]
STREM2 -.biomarker for.-> Alzheimer_s_Disease["Alzheimer's Disease"]
STREM2 -->|"upregulates"| Myelin_Debris_Phagocytosis["Myelin Debris Phagocytosis"]
STREM2 -->|"downregulates"| Lipid_Metabolism["Lipid Metabolism"]| Target | Relation | Type | Str |
|---|---|---|---|
| Alzheimer's Disease | associated_with | disease | 0.95 |
| ALZHEIMER'S DISEASE | associated_with | disease | 0.95 |
| Alzheimer'S Disease | associated_with | disease | 0.95 |
| Microglial Activation | biomarker_for | process | 0.93 |
| Total Tau | correlates_with | biomarker | 0.92 |
| Neurofilament Light | correlates_with | biomarker | 0.92 |
| Neuromyelitis Optica Spectrum Disorders | risk_factor_for | disease | 0.92 |
| Phospho-Tau | correlates_with | biomarker | 0.92 |
| Proteolytic Shedding | involved_in | process | 0.90 |
| Early-Stage Alzheimer'S Disease | associated_with | disease | 0.90 |
| PLASMA | biomarker_for | biofluid | 0.90 |
| TREM2 | associated_with | protein | 0.90 |
| Cerebrospinal Fluid | associated_with | biomarker | 0.90 |
| Plasma | associated_with | biomarker | 0.90 |
| Microglia Activity | biomarker_for | process | 0.90 |
| cerebrospinal fluid | biomarker_for | biofluid | 0.90 |
| Neuroinflammation | associated_with | process | 0.90 |
| microglial priming state | biomarker_for | phenotype | 0.90 |
| Alzheimer's disease | biomarker_for | disease | 0.90 |
| Neural Injury | correlates_with | phenotype | 0.88 |
| Alzheimer's Disease | biomarker_for | disease | 0.88 |
| Neuronal Injury | associated_with | process | 0.88 |
| Myelin Debris Phagocytosis | upregulates | process | 0.87 |
| Lipid Metabolism | downregulates | process | 0.86 |
| Alzheimer'S Disease | biomarker_for | disease | 0.85 |
| Nfkb | activates | pathway | 0.85 |
| Glycolysis | upregulates | process | 0.85 |
| NEUROINFLAMMATION | biomarker_for | process | 0.85 |
| Alzheimer'S Disease | therapeutic_target | disease | 0.85 |
| NMOSD | biomarker_for | disease | 0.80 |
| Neurodegenerative Disease | biomarker_for | disease | 0.80 |
| Neurodegenerative Disease | biomarker_for | disease | 0.80 |
| MICROGLIA | triggers_dysfunction | cell_type | 0.80 |
| microglial dysfunction | triggers | process | 0.80 |
| early Alzheimer's disease | biomarker_for | disease | 0.70 |
| Tau Pathology | biomarker_for | phenotype | 0.70 |
| microglial_activation | biomarker_for | phenotype | 0.70 |
| early symptomatic AD | biomarker_for | disease | 0.70 |
| brain TREM2 expression | biomarker_for | process | 0.70 |
| microglial burden | biomarker_for | process | 0.70 |
| Alzheimer disease | biomarker_for | disease | 0.70 |
| Alzheimer's disease stage | biomarker_for | disease | 0.70 |
| microglial proliferation | regulates | process | 0.70 |
| TREM2-agonist trials | biomarker_for | process | 0.70 |
| microglial activation state | biomarker_for | process | 0.70 |
| AD progression | biomarker_for | disease | 0.70 |
| Early AD | associated_with | disease | 0.70 |
| Source | Relation | Type | Str |
|---|---|---|---|
| TREM2 | expressed_in | gene | 0.95 |
| 37865646 | deactivates | paper | 0.90 |
| 30911003 | exerts protective role against | paper | 0.90 |
| 30911003 | reduces | paper | 0.90 |
| 30911003 | rescues | paper | 0.90 |
| 30911003 | enhances | paper | 0.90 |
| 37865646 | binds to | paper | 0.90 |
| 37865646 | induces | paper | 0.90 |
| 39817909 | propagates | paper | 0.90 |
| 38001539 | mediates | paper | 0.90 |
| TREM2 | produces | gene | 0.90 |
| ADAM10 | activates | protein | 0.90 |
| Age | upregulates | phenotype | 0.88 |
| ADAM10 | causes | gene | 0.70 |
| ADAM17 | causes | gene | 0.70 |
| 39748415 | did not show significant mediation effects on | paper | 0.60 |
| 38001539 | mediating | paper | 0.60 |
| 38001539 | is mediating | paper | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| Integrated Multi-Analyte CSF Panel Combining YKL-40, sTREM2, | 0.807 | biomarkers | What biomarkers can reliably detect micr |
| CSF sTREM2 as Pharmacodynamic Biomarker for Therapeutic Wind | 0.801 | neuroimmunology | TREM2 in Alzheimer's Disease: Mechanisms |
| sTREM2 as Biomarker of Cystatin-C Therapeutic Efficacy | 0.757 | neurodegeneration | Does the cancer-cystatin-C-TREM2 pathway |
| Soluble TREM2 (sTREM2) as Therapeutic Mimic — Decoupling Pha | 0.714 | alzheimers | TREM2 agonism vs antagonism in DAM micro |
| Dynamic Plasma Exosome-Derived Multi-Analyte Panel Combining | 0.389 | biomarkers | What biomarkers can reliably detect micr |
| Dynamic Blood-Based Exosome Panel for Real-Time Neuroinflamm | 0.380 | biomarkers | What biomarkers can reliably detect micr |
Scientific analyses that reference this entity
neurodegeneration | 2026-04-16 | 1 hypotheses Top: 0.579
neurodegeneration | 2026-04-16 | 1 hypotheses Top: 0.844
neuroimmunology | 2026-04-15 | 1 hypotheses Top: 0.670
neurodegeneration | 2026-04-12 | 0 hypotheses
neurodegeneration | 2026-04-11 | 0 hypotheses
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| Autophagy receptor identification for stress granule elimination | exploratory | neurodegenerative diseases | 0.900 | 0.00 | cultured cells under arsenite | proposed | N/A |
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| Obesity-induced pyroptotic adipocyte death leads to TREM2-dependent macrophage d [PMID:41509917] | Choi C, Lee J, Park G, Namgoong S, Lee Y | iScience | 2026 | 0 |
| Neurodegeneration and demyelination in multiple sclerosis. [PMID:38889714] | Garton T, Gadani SP, Gill AJ, Calabresi | Neuron | 2024 | 0 |
| STING orchestrates the neuronal inflammatory stress response in multiple scleros [PMID:38878778] | Woo MS, Mayer C, Binkle-Ladisch L, Sonne | Cell | 2024 | 0 |
| Gasdermin-E mediates mitochondrial damage in axons and neurodegeneration. [PMID:36917977] | Neel DV, Basu H, Gunner G, Bergstresser | Neuron | 2023 | 0 |
Multi-agent debates referencing this entity
closed · Rounds: 4 · Score: 0.59 · 2026-04-27
closed · Rounds: 4 · Score: 0.75 · 2026-04-22
closed · Rounds: 4 · Score: 0.30 · 2026-04-21
closed · Rounds: 4 · Score: 0.30 · 2026-04-21
closed · Rounds: 4 · Score: 0.70 · 2026-04-21
closed · Rounds: 4 · Score: 0.70 · 2026-04-21
closed · Rounds: 4 · Score: 0.50 · 2026-04-18
closed · Rounds: 4 · Score: 0.49 · 2026-04-18
closed · Rounds: 4 · Score: 0.70 · 2026-04-16
closed · Rounds: 4 · Score: 0.70 · 2026-04-16
Hypotheses and analyses mentioning STREM2 in their description or question text